Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
Annals of the Rheumatic Diseases|May 3, 2012
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trialsSusan Manzi, Jorge Sánchez-Guerrero, Joan T Merrill, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2022
A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus ErythematosusKenneth C Kalunian, Richard Furie, Eric F Morand, et al.
Lupus Science & Medicine|April 17, 2018
Lupus community panel proposals for optimising clinical trials: 2018Joan T Merrill, Susan Manzi, Cynthia Aranow, et al.
The Journal of Rheumatology|January 10, 2009
Apolipoprotein H promoter polymorphisms in relation to lupus and lupus-related phenotypesSangita Suresh, F Yesim K Demirci, Erin Jacobs, et al.
Arthritis and Rheumatism|December 14, 2004
Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drugSteven A Mazzuca, Kenneth D Brandt, Barry P Katz, et al.
Lupus Science & Medicine|August 16, 2019
Global consensus building and prioritisation of fundamental lupus challenges: the ALPHA projectSusan Manzi, Sandra Raymond, Karin Tse, et al.
The Journal of Rheumatology|June 19, 2012
Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trialW Winn Chatham, Daniel J Wallace, William Stohl, et al.
Arthritis and Rheumatism|June 30, 2005
Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trialKenneth D Brandt, Steven A Mazzuca, Barry P Katz, et al.
Nature Genetics|January 24, 2009
Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosusStacy L Musone, Kimberly E Taylor, Timothy T Lu, et al.
Lupus Science & Medicine|November 15, 2014
Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurementsChaim Putterman, Richard Furie, Rosalind Ramsey-Goldman, et al.
Pageof 16